{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:11:55Z","timestamp":1784740315099,"version":"3.55.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>17\u03b1-hydroxylase\/17,20-lyase deficiency (17-OHD) typically presents with sexual infantilism, hypertension, and hypokalemia. However, phenotypic variability, particularly breast development, may obscure diagnosis. This study aims to characterize an atypical presentation of 17-OHD with preserved breast development and breast nodules, and to evaluate clinical and hormonal features associated with breast development through a systematic literature review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A 38-year-old woman with bilateral breast nodules and ductal ectasia was diagnosed with 17-OHD, confirmed by\n                      <jats:italic>CYP17A1<\/jats:italic>\n                      variants. A literature review of 17-OHD cases with near-complete breast development (Tanner stage 4\u20135) was conducted to analyze clinical, hormonal, and genotypic features.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The patient exhibited classic signs of 17-OHD including hypertension, hypokalemia, adrenal hyperplasia, and hypogonadism, but also presented with atypical bilateral breast nodules and mammary duct ectasia. Hormone therapy resulted in clinical improvement and regression of the breast findings. Literature analysis of 43 patients with breast development showed that patients with 46,XX were diagnosed later than 46,XY (29.5 \u00b1 11.5 vs. 19.8 \u00b1 6.9 years,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.0095). Estradiol was more often subnormal in 46,XX, while both groups showed progesterone excess and androgen deficiency. Pubic hair development differed by karyotype (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.027), which was more advanced in the 46,XY group. Genetic data revealed that breast development was associated with non-null\n                      <jats:italic>CYP17A1<\/jats:italic>\n                      variants, and most variants clustered in exons 5\u20138, with exon 8 as a hotspot.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case broadens the phenotypic spectrum of 17-OHD, highlighting that preserved breast development and benign breast lesions may delay diagnosis. Literature review suggests partial loss-of-function variants contribute to this phenotype. Greater awareness is essential to prevent misdiagnosis and unnecessary interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1658362","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:19:00Z","timestamp":1761542340000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Bilateral breast nodules as an unusual manifestation of 17\u03b1-hydroxylase\/17,20-lyase deficiency"],"prefix":"10.3389","volume":"16","author":[{"given":"Minchun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyan","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2016.02.002","article-title":"Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic","volume":"165","author":"Auchus","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01330-7","article-title":"Congenital adrenal hyperplasia","volume":"401","author":"Auer","year":"2023","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae773","article-title":"17alpha-hydroxylase\/17,20-lyase deficiency (17-OHD): A meta-analysis of reported cases","volume":"110","author":"Willemsen","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.24953\/turkjped.2020.05.019","article-title":"Atypical presentation in patients with 17 \u03b1-hydroxylase deficiency caused by a deletion in the CYP17A1 gene: short stature","volume":"62","author":"Bolu","year":"2020","journal-title":"Turk J Pediatr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2025.1508792","article-title":"Estrogen-secreting testicular tumors in 46,XY female patients with 17\u03b1-hydroxylase\/17,20-lyase deficiency: two unusual case reports and a review of the literature","volume":"16","author":"Batatinha","year":"2025","journal-title":"Front Genet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2653","article-title":"A novel point mutation in P450c17 (CYP17) causing combined 17alpha-hydroxylase\/17,20-lyase deficiency","volume":"91","author":"Brooke","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4274\/jcrpe.galenos.2024.2024-6-21-S","article-title":"Rare types of congenital adrenal hyperplasias other than 21-hydroxylase deficiency","volume":"17","author":"\u0130sakoca","year":"2025","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.978026","article-title":"Clinical characteristics and molecular etiology of partial 17alpha-hydroxylase deficiency diagnosed in 46,XX patients","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.2401","article-title":"Functional assessment of a novel biallelic MYH3 variation causing CPSKF1B (contractures, pterygia, and spondylocarpotarsal fusion syndrome1B)","volume":"12","author":"He","year":"2024","journal-title":"Mol Genet Genomic Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2020-0478","article-title":"Clinical and genetic characteristics of 17 \u03b1-hydroxylase\/17, 20-lyase deficiency: c.985_987delTACinsAA mutation of CYP17A1 prevalent in the chinese han population","volume":"27","author":"Xia","year":"2021","journal-title":"Endocr Pract"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4158\/EP171987.OR","article-title":"17\u03b1-hydroxylase deficiency is an underdiagnosed disease: high frequency of misdiagnoses in a large cohort of Brazilian patients","volume":"24","author":"Fontenele","year":"2018","journal-title":"Endocr Pract"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-225447","article-title":"A challenging case of primary amenorrhoea","volume":"2018","author":"Sarathi","year":"2018","journal-title":"BMJ Case Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"20220548","DOI":"10.1515\/biol-2022-0548","article-title":"Refractory hypokalemia with sexual dysplasia and infertility caused by 17\u03b1-hydroxylase deficiency and triple X syndrome: A case report","volume":"18","author":"Yao","year":"2023","journal-title":"Open Life Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ21-0266","article-title":"Identification of a homozygous c.1039C>T (p.R347C) variant in CYP17A1 in a 67-year-old female patient with partial 17\u03b1-hydroxylase\/17,20-lyase deficiency","volume":"69","author":"Yamagata","year":"2022","journal-title":"Endocr J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4158\/EP14388.CR","article-title":"Elevated levels of plasma immunoassayable aldosterone in a mild form of 17 alpha-hydroxylase\/17,20-lyase deficiency diagnosed at the age of 50","volume":"1","author":"Ueda","year":"2015","journal-title":"AACE Clin Case Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.8b03901","article-title":"Human cytochrome CYP17A1: the structural basis for compromised lyase activity with 17-hydroxyprogesterone","volume":"140","author":"Mak","year":"2018","journal-title":"J Am Chem Soc"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2005.09.004","article-title":"Aromatase-independent testosterone conversion into estrogenic steroids is inhibited by a 5 alpha-reductase inhibitor","volume":"98","author":"Ishikawa","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3892\/ijmm.2021.4906","article-title":"Estrogen disorders: Interpreting the abnormal regulation of aromatase in granulosa cells (Review)","volume":"47","author":"Liu","year":"2021","journal-title":"Int J Mol Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/jcm14010158","article-title":"Endocrine hormones and their impact on pubertal gynecomastia","volume":"14","author":"Shi","year":"2024","journal-title":"J Clin Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molmed.2012.12.007","article-title":"Estrogen synthesis and signaling pathways during aging: from periphery to brain","volume":"19","author":"Cui","year":"2013","journal-title":"Trends Mol Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41574-022-00742-y","article-title":"Hormonal regulation of mammary gland development and lactation","volume":"19","author":"Hannan","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1210\/er.2008-0022","article-title":"Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions","volume":"30","author":"Kleinberg","year":"2009","journal-title":"Endocr Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2117004119","article-title":"Progesterone activates GPR126 to promote breast cancer development via the Gi pathway","volume":"119","author":"An","year":"2022","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnz001","article-title":"Progesterone and breast cancer","volume":"41","author":"Trabert","year":"2020","journal-title":"Endocr Rev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2021.0344","article-title":"Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells","volume":"19","author":"Deng","year":"2021","journal-title":"Cancer Biol Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"182ra55","DOI":"10.1126\/scitranslmed.3005654","article-title":"Progesterone\/RANKL is a major regulatory axis in the human breast","volume":"5","author":"Tanos","year":"2013","journal-title":"Sci Transl Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.stem.2023.12.002","article-title":"Mechanosensitive hormone signaling promotes mammary progenitor expansion and breast cancer risk","volume":"31","author":"Northey","year":"2024","journal-title":"Cell Stem Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/humu.20237","article-title":"A protein-truncating mutation in CYP17A1 in three sisters with early-onset breast cancer","volume":"26","author":"Hopper","year":"2005","journal-title":"Hum Mutat"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2015.02.007","article-title":"New, recurrent, and prevalent mutations: Clinical and molecular characterization of 26 Chinese patients with 17alpha-hydroxylase\/17,20-lyase deficiency","volume":"150","author":"Zhang","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/mend.13.7.0326","article-title":"Molecular modeling of human P450c17 (17alpha-hydroxylase\/17,20-lyase): insights into reaction mechanisms and effects of mutations","volume":"13","author":"Auchus","year":"1999","journal-title":"Mol Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2001-011880","article-title":"Differential inhibition of 17alpha-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency","volume":"87","author":"Van Den Akker","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1210\/clinem\/dgae414","article-title":"CYP17A1 pathogenic variants in 26 Chinese patients with 17\u03b1-hydroxylase deficiency by targeted long-read sequencing","volume":"110","author":"Cao","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13048-023-01190-6","article-title":"Endocrine profiles and cycle characteristics of infertile 17\u03b1-hydroxylase\/17,20-lyase Deficiency Patients undergoing assisted Reproduction Treatment: a retrospective cohort study","volume":"16","author":"Pan","year":"2023","journal-title":"J Ovarian Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2014.943721","article-title":"Clinical and genetic analyses of a Chinese female with 17\u03b1-hydroxylase\/17,20-lyase deficiency","volume":"30","author":"Shi","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.2000.3134","article-title":"Mutation of proline 409 to arginine in the meander region of cytochrome p450c17 causes severe 17 alpha-hydroxylase deficiency","volume":"72","author":"Lam","year":"2001","journal-title":"Mol Genet Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0712","article-title":"Metabolic evidence for impaired 17alpha-hydroxylase activity in a kindred bearing the E305G mutation for isolate 17,20-lyase activity","volume":"158","author":"Tiosano","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2013.10.006","article-title":"An alternative explanation of hypertension associated with 17\u03b1-hydroxylase deficiency syndrome","volume":"79","author":"Morris","year":"2014","journal-title":"Steroids"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1658362\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:19:01Z","timestamp":1761542341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1658362\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":38,"alternative-id":["10.3389\/fendo.2025.1658362"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1658362","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"article-number":"1658362"}}